Stanford University
Showing 111-120 of 144 Results
-
Philip Oyer
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus
Current Research and Scholarly InterestsDevelopment of an artificial heart assist device; heart, and heart-lung transplantation.
-
Yellappa Palagani
Postdoctoral Scholar, Cardiothoracic Surgery
BioYellappa Palagani is currently a Postdoctoral Fellow in Cardiothoracic Surgery at Stanford University. In Dr Ma's lab, he is developing an MRI-compatible mock circulatory loop using cardiac phantoms to simulate complex congenital heart defects, an ex-vivo preservation system for pediatric heart transplantation, and an adjustable pulmonary artery band for managing congenital heart diseases. Before joining Stanford, he was a Postdoctoral Associate in Adult Cardiac Surgery at Yale University from April 2021 to March 2023, where he worked under the supervision of Pramod Bonde, MD, on left ventricular assist devices and smart inductive stents. In August 2020, he received his PhD in Electronics Engineering from Kyungpook National University, South Korea, under the supervision of Jun Rim Choi, PhD. During his doctoral program, he worked on wirelessly powered cardiac pacemakers and wearable cardiac arrhythmia indicators.
-
Ed Petrossian
Clinical Professor, Cardiothoracic Surgery
Current Research and Scholarly InterestsDr. Petrossian has expertise in complex pediatric and congenital cardiovascular surgical repairs. He has published several journal articles and book chapters with an emphasis on the extracardiac conduit Fontan operation.
-
Olaf Reinhartz
Clinical Associate Professor, Cardiothoracic Surgery
Current Research and Scholarly Interests1. Mechanical circulatory support in failing Fontan circulation
2. Pathophysiologic response to fetal cardiac surgery.
3. Various clinical projects in pediatric cardiothoracic surgery -
Bruce A Reitz
Norman E. Shumway Professor, Emeritus
Current Research and Scholarly InterestsMechanism of allograft rejection for the heart and, lung; late chronic effects of rejection, such as graft coronary, atherosclerosis in the heart and bronchiolitis obliterans in the, lung; treatment of rejection, including pharmacologic agents, total, lymphoid irradiation, and the induction of tolerance in fetal, animals; clinical studies include the results of lung and heart-lung, transplantation, modification of immunosuppressive protocols, and, factors contributing to late chronic rejection.
